Disclosure of Events or Information

Press Release - Eugia Pharma announces launch of Pomalidomide Capsules in the US

Clarification on media report, Aurobindo Pharmas P Sarath Chandra Reddy acquitted in Delhi Liquor Scam case

Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Ltd.,

Press Release - Eugia Pharma receives USFDA Approval for Everolimus Tablets

Incorporation of Engenra Biologics Private Limited

Intimation of Orders received from CGST, Hyderabad

Clarification on news item appearing in https:www.ndtvprofit.com

Press Release - Acrotech Biopharma Inc., Announces FDA Approval of ADQUEYTM difamilast 1 Ointment

Completion of US FDA Inspection at Unit-VII of Aurobindo Pharma Limited, Jedcherla

Outcome of Board Meeting 09.02.2026

Completion of US FDA Inspection at Unit-III of Eugia Pharma Specialities Limited

Clarification on Significant Volume Movement in Companys Shares

Incorporation of a new wholly owned step-down subsidiary in Philippines

CuraTeQ Biologics receives NOC from Health Canada for its biosimilar Dyrupeg

Acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Pvt.Ltd., by Auro Pharma Limited